Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — Q1 2024 Earnings Presentation
15 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Apr 25, 2024
Slide 1: Q1 Conference Call
Q1 Conference Call Drägerwerk AG & Co. KGaA April 25, 2024, Lübeck
Slide 2: Disclaimer
Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future
Slide 3: Agenda
Agenda — 01 Dräger Business Highlights 02 Financials Q1 2024 03 Outlook FY 2024 Drägerwerk AG & Co. KGaA 3
Slide 4: Dräger Business Highlights
01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4
Slide 5: Q1 2024 Highlights
Q1 2024 Solid business Positive result with performance earnings and net sales Highlights below Q1 ’23 as expected Technology for Life remains in demand: Order intake above the Positive operating result in high level of the prior-year quarter traditionally weak first quarter; earnings and net sales
Slide 6: Financials Q1 2024
02 Financials Q1 2024 Drägerwerk AG & Co. KGaA 6
Slide 7: Business development Group
Business development Group Order entry Q1 2023 Q1 2024 Change — (€ million) (fx-adj.) Germany 200,7 212,1 +5.7 EMEA 288,8 312,0 +7.9 Net sales (€ million) Americas 143,4 160,4 +10.8 -2.6% APAC 170,8 126,3 -22.2 fx-adj -3.3% Total 803.8 810.8 +1.5 nominal 761 736 • Order entry slightly above high pri
Slide 8: Business development Medical
Business development Medical Order entry Q1 2023 Q1 2024 Change — (€ million) (fx-adj.) Germany 107.1 108.2 +1.0 EMEA 148.3 159.4 +7.5 Net sales (€ million) Americas 88.4 106.9 +18.9 -10.4% APAC 121.5 79.2 -31.1 fx-adj -11.2% Total 465.3 453.7 -1.9 nominal 470 417 • Order entry slightly below prior-
Slide 9: Business development Safety
Business development Safety Order entry Q1 2023 Q1 2024 Change — (€ million) (fx-adj.) Germany 93,7 104,0 +11.0 EMEA 140,4 152,6 +8.3 Net sales (€ million) Americas 54,9 53,5 -2.2 +10.0% APAC 49,4 47,1 -0.1 fx-adj +9.3% Total 338,4 357,2 +6.1 nominal 291 318 • Order entry increased, driven by occupa
Slide 10: Key figures
Key figures Q1 2024 Q1 2023 Change € million € million % Cashflow (from operating activities) 33.5 -4.2 >+100 Investments 22.7 30.4 -25.2 Cash and cash equivalents1 211.7 219.6 -3.6 Net financial debt1 192.4 290.4 -33.7 Net financial debt1 / EBITDA2 0.6 2.4 Capital employed 1 1,526.5 1,569.2 -2.7 RO
Slide 11: Outlook FY 2024
03 Outlook FY 2024 Drägerwerk AG & Co. KGaA 11
Slide 12: Outlook
Outlook Results achieved Forecast for for fiscal year 2023 fiscal year 2024 Net sales (net of currency effects) 13.1% 1.0 to 5.0% Gross margin 43.3% 43.0 to 45.0% EBIT margin 4.9% 2.5 to 5.5% Dräger Value Added (DVA) EUR 55.8 million EUR -60 to 40 million Drägerwerk AG & Co. KGaA 12
Slide 13: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA 13
Slide 14: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 7, 2024 Annual Report 2023 Conference call April 25, 2024 Report for the first three months 2024 Conference c
Slide 15: Thank you
Thank you Thomas Fischler Nikolaus Hammerschmidt Head of Treasury & Investor Relations Investor Relations Manager Moislinger Alle 53-55 Moislinger Alle 53-55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel. +49 451 882 2685 Tel. +49 451 882 8903 Mail: thomas.fischler@draeger.com Mail: nikolaus.hamme
Drägerwerk AG & Co. KGaA — Q1 2024 Earnings Presentation on 6ix